Logo image of EBON

EBANG INTERNATIONAL HLDGS-A (EBON) Stock Fundamental Analysis

USA - NASDAQ:EBON - KYG3R33A2053 - Common Stock

4.68 USD
-0.27 (-5.45%)
Last: 9/16/2025, 8:13:18 PM
4.73 USD
+0.05 (+1.07%)
After Hours: 9/16/2025, 8:13:18 PM
Fundamental Rating

3

Overall EBON gets a fundamental rating of 3 out of 10. We evaluated EBON against 33 industry peers in the Technology Hardware, Storage & Peripherals industry. EBON has a great financial health rating, but its profitability evaluates not so good. EBON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EBON has reported negative net income.
EBON had negative earnings in 4 of the past 5 years.
In the past 5 years EBON reported 4 times negative operating cash flow.
EBON Yearly Net Income VS EBIT VS OCF VS FCFEBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

EBON has a Return On Assets (-6.91%) which is comparable to the rest of the industry.
EBON has a Return On Equity of -7.29%. This is in the better half of the industry: EBON outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -6.91%
ROE -7.29%
ROIC N/A
ROA(3y)-10.81%
ROA(5y)-10.51%
ROE(3y)-11.56%
ROE(5y)-12.65%
ROIC(3y)N/A
ROIC(5y)N/A
EBON Yearly ROA, ROE, ROICEBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

EBON has a worse Gross Margin (6.14%) than 87.88% of its industry peers.
EBON's Gross Margin has declined in the last couple of years.
EBON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.02%
GM growth 5YN/A
EBON Yearly Profit, Operating, Gross MarginsEBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

7

2. Health

2.1 Basic Checks

EBON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EBON remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EBON has less shares outstanding
There is no outstanding debt for EBON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EBON Yearly Shares OutstandingEBON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EBON Yearly Total Debt VS Total AssetsEBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

EBON has an Altman-Z score of 1.29. This is a bad value and indicates that EBON is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EBON (1.29) is worse than 60.61% of its industry peers.
EBON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACCN/A
WACC8.69%
EBON Yearly LT Debt VS Equity VS FCFEBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 22.40 indicates that EBON has no problem at all paying its short term obligations.
EBON's Current ratio of 22.40 is amongst the best of the industry. EBON outperforms 96.97% of its industry peers.
EBON has a Quick Ratio of 22.30. This indicates that EBON is financially healthy and has no problem in meeting its short term obligations.
EBON has a Quick ratio of 22.30. This is amongst the best in the industry. EBON outperforms 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 22.4
Quick Ratio 22.3
EBON Yearly Current Assets VS Current LiabilitesEBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

EBON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.32%, which is quite impressive.
The Revenue has grown by 154.51% in the past year. This is a very strong growth!
Measured over the past years, EBON shows a very negative growth in Revenue. The Revenue has been decreasing by -44.26% on average per year.
EPS 1Y (TTM)47.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)154.51%
Revenue growth 3Y-51.51%
Revenue growth 5Y-44.26%
Sales Q2Q%69.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EBON Yearly Revenue VS EstimatesEBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EBON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EBON Price Earnings VS Forward Price EarningsEBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EBON Per share dataEBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EBON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EBANG INTERNATIONAL HLDGS-A

NASDAQ:EBON (9/16/2025, 8:13:18 PM)

After market: 4.73 +0.05 (+1.07%)

4.68

-0.27 (-5.45%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)04-28 2025-04-28
Earnings (Next)N/A N/A
Inst Owners2.78%
Inst Owner Change9.47%
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap29.39M
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.01
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-2.95
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.17
BVpS40.45
TBVpS39.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.91%
ROE -7.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.14%
FCFM N/A
ROA(3y)-10.81%
ROA(5y)-10.51%
ROE(3y)-11.56%
ROE(5y)-12.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.02%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 22.4
Quick Ratio 22.3
Altman-Z 1.29
F-ScoreN/A
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)116.47%
Cap/Depr(5y)160.77%
Cap/Sales(3y)49.35%
Cap/Sales(5y)56.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)154.51%
Revenue growth 3Y-51.51%
Revenue growth 5Y-44.26%
Sales Q2Q%69.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-76.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50%
OCF growth 3YN/A
OCF growth 5YN/A